Michael Cloonan - Net Worth and Insider Trading

Michael Cloonan Net Worth

The estimated net worth of Michael Cloonan is at least $2,642 dollars as of 2024-11-13. Michael Cloonan is the Chief Business Officer of Sage Therapeutics Inc and owns about 461 shares of Sage Therapeutics Inc (SAGE) stock worth over $2,642. Details can be seen in Michael Cloonan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael Cloonan has not made any transactions after 2019-05-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Michael Cloonan

To

Michael Cloonan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael Cloonan owns 1 companies in total, including Sage Therapeutics Inc (SAGE) .

Click here to see the complete history of Michael Cloonan’s form 4 insider trades.

Insider Ownership Summary of Michael Cloonan

Ticker Comapny Transaction Date Type of Owner
SAGE Sage Therapeutics Inc 2019-05-22 Chief Business Officer

Michael Cloonan Latest Holdings Summary

Michael Cloonan currently owns a total of 1 stock. Michael Cloonan owns 461 shares of Sage Therapeutics Inc (SAGE) as of May 22, 2019, with a value of $2,642.

Latest Holdings of Michael Cloonan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SAGE Sage Therapeutics Inc 2019-05-22 461 5.73 2,642

Holding Weightings of Michael Cloonan


Michael Cloonan Form 4 Trading Tracker

According to the SEC Form 4 filings, Michael Cloonan has made a total of 0 transactions in Sage Therapeutics Inc (SAGE) over the past 5 years. The most-recent trade in Sage Therapeutics Inc is the sale of 25,000 shares on May 22, 2019, which brought Michael Cloonan around $4 Million.

Insider Trading History of Michael Cloonan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Michael Cloonan Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Michael Cloonan Ownership Network

Ownership Network List of Michael Cloonan

No Data

Ownership Network Relation of Michael Cloonan

Insider Network Chart

Michael Cloonan Owned Company Details

What does Sage Therapeutics Inc do?

Who are the key executives at Sage Therapeutics Inc?

Michael Cloonan is the Chief Business Officer of Sage Therapeutics Inc. Other key executives at Sage Therapeutics Inc include director & See Remarks Jeffrey M Jonas , Chief Medical Officer Laura Gault , and Chief Commercial Officer Christopher Benecchi .

Sage Therapeutics Inc (SAGE) Insider Trades Summary

Over the past 18 months, Michael Cloonan made no insider transaction in Sage Therapeutics Inc (SAGE). Other recent insider transactions involving Sage Therapeutics Inc (SAGE) include a net purchase of 2,000 shares made by Elizabeth Barrett ,

In summary, during the past 3 months, insiders sold 0 shares of Sage Therapeutics Inc (SAGE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sage Therapeutics Inc (SAGE) were sold and 2,000 shares were bought by its insiders, resulting in a net purchase of 2,000 shares.

Sage Therapeutics Inc (SAGE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Sage Therapeutics Inc Insider Transactions

No Available Data

Michael Cloonan Mailing Address

Above is the net worth, insider trading, and ownership report for Michael Cloonan. You might contact Michael Cloonan via mailing address: C/o Sage Therapeutics, Inc., 215 First Street, Cambridge Ma 02142.